Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma.

Xu J, Liu JL, Medeiros LJ, Huang W, Khoury JD, McDonnell TJ, Tang G, Schlette E, Yin CC, Bueso-Ramos CE, Lin P, Li S.

Eur J Haematol. 2020 Jan 15. doi: 10.1111/ejh.13384. [Epub ahead of print]

PMID:
31944390
2.

Achieving Complete Remission in CLL Patients Treated with Ibrutinib: Clinical Significance and Predictive Factors.

Strati P, Schlette EJ, Solis Soto L, Dueñas-Hancco DE, Sivina M, Kim E, Keating M, Wierda WG, Ferrajoli A, Kantarjian H, Estrov Z, Jain N, Thompson PA, Wistuba II, Burger JA.

Blood. 2020 Jan 2. pii: blood.2019003570. doi: 10.1182/blood.2019003570. [Epub ahead of print] No abstract available.

PMID:
31895947
3.

A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma.

Lyapichev KA, Piña-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RN.

Mod Pathol. 2019 Aug 5. doi: 10.1038/s41379-019-0337-2. [Epub ahead of print]

PMID:
31383966
4.

Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.

Garces S, Khoury JD, Kanagal-Shamanna R, Salem A, Wang SA, Ok CY, Hu S, Patel KP, Routbort MJ, Luthra R, Tang G, Schlette EJ, Bueso-Ramos CE, Medeiros LJ, Loghavi S.

Hum Pathol. 2018 Dec;82:215-231. doi: 10.1016/j.humpath.2018.07.030. Epub 2018 Aug 4.

PMID:
30086334
5.

Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.

Liu H, Wang SA, Schlette EJ, Xu J, Jorgensen JL, Cameron Yin C, Li S, Jeffrey Medeiros L, Tang G.

Ann Hematol. 2018 Oct;97(10):1775-1783. doi: 10.1007/s00277-018-3389-3. Epub 2018 Jun 5.

PMID:
29872884
6.

Epstein-Barr virus-positive follicular lymphoma.

Kurt H, Medeiros LJ, Khoury JD, Schlette EJ.

Br J Haematol. 2018 Sep;182(6):757. doi: 10.1111/bjh.15419. Epub 2018 May 29. No abstract available.

PMID:
29808924
7.

CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.

Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA.

Mod Pathol. 2018 Feb;31(2):327-336. doi: 10.1038/modpathol.2017.135. Epub 2017 Oct 6.

8.

Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.

Boddu P, Schlette E, Thakral B, Tang G, Pemmaraju N, Kadia T, Ferrajoli A, Ravandi F, Wierda W, Jain N.

Hematol Oncol Stem Cell Ther. 2019 Sep;12(3):161-165. doi: 10.1016/j.hemonc.2017.07.004. Epub 2017 Aug 16.

9.

Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma.

Hidalgo Lopez JE, Yabe M, Carballo-Zarate AA, Wang SA, Jorgensen JL, Ahmed S, Lee J, Li S, Schlette E, McDonnell T, Miranda RN, Medeiros LJ, Bueso-Ramos CE, Yin CC.

J Natl Compr Canc Netw. 2016 Aug;14(8):939-44.

PMID:
27496109
10.

Diffuse large B-cell lymphoma with microsatellite instability developing in the setting of Muir-Torre variant hereditary non-polyposis colon cancer.

Cheah CY, Dsouza L, Taggart MW, Schlette EJ, Turturro F.

J Clin Pathol. 2015 Sep;68(9):755-7. doi: 10.1136/jclinpath-2015-203039. Epub 2015 May 25. No abstract available.

PMID:
26008772
11.

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia.

Falchi L, Keating MJ, Marom EM, Truong MT, Schlette EJ, Sargent RL, Trinh L, Wang X, Smith SC, Jain N, Estrov Z, O'Brien S, Wierda WG, Lerner S, Ferrajoli A.

Blood. 2014 May 1;123(18):2783-90. doi: 10.1182/blood-2013-11-536169. Epub 2014 Mar 10.

12.

c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma.

Leventaki V, Drakos E, Karanikou M, Psatha K, Lin P, Schlette E, Eliopoulos A, Vassilakopoulos TP, Papadaki H, Patsouris E, Medeiros LJ, Rassidakis GZ.

Hum Pathol. 2014 Mar;45(3):565-72. doi: 10.1016/j.humpath.2013.10.024. Epub 2013 Oct 31.

PMID:
24457077
13.

Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation.

Munoz J, Schlette E, Kurzrock R.

J Clin Oncol. 2013 Jul 10;31(20):e351-2. doi: 10.1200/JCO.2012.45.7739. Epub 2013 Jun 3. No abstract available.

PMID:
23733763
14.

Late extramedullary recurrence of adult onset Burkitt's lymphoma mimicking peritoneal carcinomatosis.

Jain P, Benjamini O, Schlette E, Thomas DA, O'Brien S.

Am J Hematol. 2013 Oct;88(10):920-1. doi: 10.1002/ajh.23480. Epub 2013 Jun 20. No abstract available.

15.

Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?

Benjamini O, Jain P, Schlette E, Sciffman JS, Estrov Z, Keating M.

Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):338-41. doi: 10.1016/j.clml.2012.12.007. Epub 2013 Jan 16. No abstract available.

16.

Reverse-hybrid robotic mesorectal excision for rectal cancer.

Park IJ, You YN, Schlette E, Nguyen S, Skibber JM, Rodriguez-Bigas MA, Chang GJ.

Dis Colon Rectum. 2012 Feb;55(2):228-33. doi: 10.1097/DCR.0b013e31823c0bd2.

17.

Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.

Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, Garcia-Manero G, Cortes J, Thomas D, Koller CA, Burger JA, Lerner S, Schlette E, Abruzzo L, Kantarjian HM, Keating MJ.

J Clin Oncol. 2011 Nov 1;29(31):4088-95. doi: 10.1200/JCO.2010.33.9002. Epub 2011 Oct 3.

18.

ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.

Singh RR, Kunkalla K, Qu C, Schlette E, Neelapu SS, Samaniego F, Vega F.

Oncogene. 2011 Dec 8;30(49):4874-86. doi: 10.1038/onc.2011.195. Epub 2011 May 30.

19.

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).

Drakos E, Singh RR, Rassidakis GZ, Schlette E, Li J, Claret FX, Ford RJ Jr, Vega F, Medeiros LJ.

Leukemia. 2011 May;25(5):856-67. doi: 10.1038/leu.2011.28. Epub 2011 Mar 11.

20.

Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma.

Vishwamitra D, Shi P, Wilson D, Manshouri R, Vega F, Schlette EJ, Amin HM.

Haematologica. 2011 Jun;96(6):871-80. doi: 10.3324/haematol.2010.031567. Epub 2011 Feb 17.

Supplemental Content

Loading ...
Support Center